Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
At a glance Direct drug interaction / None identified in FDA labeling or Natural Medicines database Safe B6 ceiling / Under 100 mg/day per the Institute of Medicine Tolerable Upper Intake Level Neuropathy threshold / Chronic intake above 200 mg/day most consistently linked to sensory neuropathy Tirzepatide GI absorption note / Delayed gastric emptying may slow B6 absorption but does not reduce total bioavailability Recommended separation window / 1 hour before or 2 hours after Zepbound injection if GI symptoms are present B6 RDA for adults / 1.3 to 1.7 mg/day depending on age and sex Monitoring / Serum pyridoxal 5'-phosphate (PLP) if supplementing above 50 mg/day while on tirzepatide Weight-loss context / Caloric restriction on GLP-1 therapy can reduce dietary B6 intake, making modest supplementation reasonable No Direct Pharmacokinetic Interaction Exists Between Tirzepatide and Vitamin B6 Tirzepatide, the dual GIP/GLP-1 receptor agonist in Zepbound, is a 39-amino-acid peptide administered subcutaneously once weekly
Unlike GLP-1, GIP increases the secretion of another hormone, glucagon
Prior to joining Littler, Tony was a partner at the Boston law firm of Ropes & Gray
It has a shorter duration of action, which is why it must be injected daily
